Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years

John M D Thompson1, Karen E Waldie2, Clare R Wall3

  • 1Department of Paediatrics, The University of Auckland, Auckland, New Zealand.

Plos One
|September 25, 2014
PubMed

Insights

Acetaminophen use during pregnancy was linked to higher ADHD symptoms in children. This study confirms acetaminophen

Area of Science:

  • Neurodevelopmental disorders
  • Pediatric behavioral science
  • Prenatal exposure research

Background:

  • Acetaminophen (paracetamol) is a common over-the-counter pain reliever and fever reducer.
  • Previous research suggests a potential association between prenatal acetaminophen exposure and attention-deficit/hyperactivity disorder (ADHD) symptoms in children.
  • Further investigation is needed to confirm and understand this association.

Purpose of the Study:

  • To replicate and extend the observed association between acetaminophen use during pregnancy and ADHD symptoms in school-aged children.
  • To investigate the specificity of this association by examining other commonly used medications during pregnancy.

Main Methods:

  • Analysis of data from the Auckland Birthweight Collaborative Study, a longitudinal cohort of 871 European infants.
  • Assessment of drug use during pregnancy (acetaminophen, aspirin, antacids, antibiotics) via parent report.
  • Evaluation of behavioral difficulties and ADHD symptoms at ages 7 and 11 using parent and child reports (Strengths and Difficulty Questionnaire, Conners' Parent Rating Scale-Revised).
  • Inclusion of covariates such as birthweight, socioeconomic status, and maternal stress.

Main Results:

  • Nearly half (49.8%) of mothers reported using acetaminophen during pregnancy.
  • Acetaminophen use during pregnancy was significantly associated with higher total difficulty scores at ages 7 and 11.
  • Children exposed to acetaminophen in utero showed an increased risk for ADHD symptoms at both 7 and 11 years of age.
  • No significant associations were found between the use of aspirin, antacids, or antibiotics during pregnancy and ADHD symptoms.

Conclusions:

  • Findings strengthen the evidence linking prenatal acetaminophen exposure to an increased risk of ADHD-like behaviors.
  • The study supports the specificity of this association to acetaminophen, as other medications did not show similar links.
  • These results highlight the importance of considering the potential neurodevelopmental impact of common medications used during pregnancy.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
226
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Phase II Reactions: Acetylation Reactions01:24

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
1.1K
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
228